Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 30, Issue 10, Pages 1665-1673
Publisher
Oxford University Press (OUP)
Online
2015-08-04
DOI
10.1093/ndt/gfv302
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Associations between Race and Geographic Area and Quality-of-Care Indicators in Patients Approaching ESRD
- (2013) G. Yan et al. Clinical Journal of the American Society of Nephrology
- Red blood cell transfusion use in patients with chronic kidney disease
- (2013) Karminder S. Gill et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
- (2013) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Red Cell Transfusions on Future Kidney Transplantation
- (2012) G. T. Obrador et al. Clinical Journal of the American Society of Nephrology
- Dose-finding Study of Peginesatide for Anemia Correction in Chronic Kidney Disease Patients
- (2011) I. C. Macdougall et al. Clinical Journal of the American Society of Nephrology
- Intestinal Hypoxia-inducible Factor-2α (HIF-2α) Is Critical for Efficient Erythropoiesis
- (2011) Erik R. Anderson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
- (2011) S. D. Roger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD: a Propensity-Matched Observational Study
- (2010) S. Seliger et al. Clinical Journal of the American Society of Nephrology
- Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency
- (2009) Yatrik M. Shah et al. Cell Metabolism
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The non-haematopoietic biological effects of erythropoietin
- (2008) Murat O. Arcasoy BRITISH JOURNAL OF HAEMATOLOGY
- C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis: Results of a Randomized Clinical Trial
- (2008) I. C. Macdougall et al. Clinical Journal of the American Society of Nephrology
- Ferumoxytol for Treating Iron Deficiency Anemia in CKD
- (2008) B. S. Spinowitz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study
- (2008) R. Perez-Garcia et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started